YES1 as a Possible Liquid Biopsy Biomarker in Lung Cancer

Autor: N. Otegui, E. Redin, E. Janthus-Lewintre, S. Calabuig, M. Echepare, K. Valencia, S. Leon, M. Serrano, C. Camps, L. Montuenga, A. Calvo

Publikováno v: The Journal of Liquid Biopsy, Vol 1, Iss , Pp 100089- (2023)

Externí odkaz: https://doaj.org/article/0f31ab556f504ac1ad1c049dfd4c4cd1

FP16.01 Development and Characterization of Two Novel Squamous Cell Lung Cancer Mouse Cell Lines

Autor: Karmele Valencia, Cristina Bértolo, Luis M. Montuenga, Cristina Sainz, M. Echepare

Publikováno v: Journal of Thoracic Oncology. 16:S972-S973

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4095263a85fe4797cde258178d1628a0
https://doi.org/10.1016/j.jtho.2021.08.257

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

DSTYK Inhibition Sensitizes Non-Small Cell Lung Cancer To Taxane-Based Chemotherapy.

Autor: Echepare M; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain; Consorcio de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Health Research Institute (IDISNA), Pamplona, Spain., Picabea B; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain., Arricibita A; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain., Teijeira Á; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain; Consorcio de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Health Research Institute (IDISNA), Pamplona, Spain; Program of Immunology and Immunotherapy, CIMA-University of Navarra, Pamplona, Spain., Pasquier A; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain., Zandueta C; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain., Otegui N; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain., Santamaría E; Navarra Health Research Institute (IDISNA), Pamplona, Spain; Clinical Neuroproteomics Unit, Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain., Fernández-Irigoyen J; Navarra Health Research Institute (IDISNA), Pamplona, Spain; Clinical Neuroproteomics Unit, Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain., Romero O; Cancer Genetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain., Sanchez-Cespedes M; Cancer Genetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain., Lecanda F; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain., Hernández J; Department of Pathology, Hospital Universitari Vall d'Hebron & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Felip E; Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VIHO), Universitat Autonoma de Barcelona, Spain., Cruz-Bermúdez A; Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Madrid, Spain., Provencio M; Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Madrid, Spain., Gentili M; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Facchinetti F; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Roz L; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Montuenga LM; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain; Consorcio de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Health Research Institute (IDISNA), Pamplona, Spain., Valencia K; Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain; Consorcio de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Health Research Institute (IDISNA), Pamplona, Spain; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain. Electronic address: kvalencia@unav.es.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.